These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2197076)

  • 1. Dexfenfluramine. Its place in weight control.
    Turner P
    Drugs; 1990; 39 Suppl 3():53-62. PubMed ID: 2197076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexfenfluramine. An updated review of its therapeutic use in the management of obesity.
    Davis R; Faulds D
    Drugs; 1996 Nov; 52(5):696-724. PubMed ID: 9118819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dexfenfluramine on eating habits in a Dutch ambulatory android overweight population with an overconsumption of snacks.
    Drent ML; Zelissen PM; Koppeschaar HP; Nieuwenhuyzen Kruseman AC; Lutterman JA; van der Veen EA
    Int J Obes Relat Metab Disord; 1995 May; 19(5):299-304. PubMed ID: 7647820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexfenfluramine in the treatment of severe obesity: a placebo-controlled investigation of the effects on weight loss, cardiovascular risk factors, food intake and eating behaviour.
    Mathus-Vliegen EM; van de Voorde K; Kok AM; Res AM
    J Intern Med; 1992 Aug; 232(2):119-27. PubMed ID: 1506807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity.
    McTavish D; Heel RC
    Drugs; 1992 May; 43(5):713-33. PubMed ID: 1379149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dexfenfluramine and feeding behavior. Clinical and pharmacoclinical studies].
    Fantino M
    Ann Med Interne (Paris); 1989; 140 Suppl 1():12-6. PubMed ID: 2672935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexfenfluramine influences dietary compliance and eating behaviors of obese subjects.
    Nutr Rev; 1994 Feb; 52(2 Pt 1):65-8. PubMed ID: 8183472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexfenfluramine hydrochloride: an anorexigenic agent.
    Bever KA; Perry PJ
    Am J Health Syst Pharm; 1997 Sep; 54(18):2059-72. PubMed ID: 9377205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexfenfluramine influences dietary compliance and eating behavior, but dietary instruction may overrule its effect on food selection in obese subjects.
    Mathus-Vliegen LM; Res AM
    J Am Diet Assoc; 1993 Oct; 93(10):1163-5. PubMed ID: 8409140
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of dexfenfluramine on eating behavior and body weight of obese patients: results of a field study of Isomeride in Austrian general practice].
    Geyer G; Haidinger G; Francesconi M; Langmayr N; Prager R; Schoberberger R; Toplak H; von Kalckreuth G; Kunze M
    Acta Med Austriaca; 1995; 22(5):95-101; 104-9. PubMed ID: 8651045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexfenfluramine treatment of obesity: a double blind trial with post trial follow up.
    O'Connor HT; Richman RM; Steinbeck KS; Caterson ID
    Int J Obes Relat Metab Disord; 1995 Mar; 19(3):181-9. PubMed ID: 7780494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A multicenter open study of dexfenfluramine in Italy. The efficacy and safety of using dexfenfluramine in treating patients with simple or complicated obesity. The DIMOS Group].
    Enzi G
    Ter Arkh; 1997; 69(5):71-5. PubMed ID: 9235665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 6 months therapy with dexfenfluramine in obese patients: studies in the United Kingdom.
    Finer N; Craddock D; Lavielle R; Keen H
    Clin Neuropharmacol; 1988; 11 Suppl 1():S179-86. PubMed ID: 3052816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A close look at fenfluramine and dexfenfluramine.
    Vivero LE; Anderson PO; Clark RF
    J Emerg Med; 1998; 16(2):197-205. PubMed ID: 9543401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Place of dexfenfluramine in the management of obesity.
    Guy-Grand BJ
    Clin Neuropharmacol; 1988; 11 Suppl 1():S216-23. PubMed ID: 3052820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of fenfluramine and dexfenfluramine in the treatment of obesity: a meta-analysis.
    Carvajal A; García del Pozo J; Martín de Diego I; Rueda de Castro AM; Velasco A
    Methods Find Exp Clin Pharmacol; 2000 Jun; 22(5):285-90. PubMed ID: 11031729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged weight loss with dexfenfluramine treatment in obese patients.
    Finer N; Craddock D; Lavielle R; Keen H
    Diabete Metab; 1987; 13(6):598-602. PubMed ID: 3329122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dexfenfluramine on gastric emptying of a mixed solid-liquid meal in obese subjects.
    Horowitz M; Maddox A; Wishart J; Vernon-Roberts J; Chatterton B; Shearman D
    Br J Nutr; 1990 May; 63(3):447-55. PubMed ID: 2383524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexfenfluramine reduces cardiovascular risk factors.
    Bremer JM; Scott RS; Lintott CJ
    Int J Obes Relat Metab Disord; 1994 Apr; 18(4):199-205. PubMed ID: 8044193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and safety of dexfenfluramine treatment in obese adolescents].
    Małecka-Tendera E; Koehler B; Muchacka M; Wazowski R; Trzciakowska A
    Pediatr Pol; 1996 May; 71(5):431-6. PubMed ID: 8710426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.